✦ LIBER ✦

Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor

✍ Scribed by Junjiro Ohshima; Masayuki Haruta; Yasuhito Arai; Fumio Kasai; Yuiko Fujiwara; Tadashi Ariga; Hajime Okita; Masahiro Fukuzawa; Jun-Ichi Hata; Hiroshi Horie; Yasuhiko Kaneko

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 433 KB
Volume: 48
Category: Article
ISSN: 1045-2257
DOI: 10.1002/gcc.20705

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A SNP‐based array analysis of 100 Wilms tumors (WT) from 97 patients identified 7p alterations (hemizygous and homozygous deletions and uniparental disomy) in nine tumors. The homozygous deletion (HD) region of 7p21 found in one tumor partially overlapped with another HD region reported previously, and was narrowed down to a 2.1‐Mb region. Based on an expression analysis of 10 genes located in the HD region in 3 WT lines and previous studies on tumorigenic roles of MEOX2 and SOSTDC1, we further analyzed these two genes. Sequencing showed no mutation in MEOX2, but two missense mutations (L50F and Q129L) in SOSTDC1 in four tumors; L50F in two tumors was of germline origin. Expression levels (0, 1+ and 2+) of MEOX2 were lower in four tumors with 7p alterations than in 18 tumors with no 7p alterations (P = 0.017), and those of SOSTDC1 tended to be lower in five tumors with 7p alterations or SOSTDC1 mutation than in 17 tumors with no 7p alterations or SOSTDC1 mutation (P = 0.056). There were no significant differences in clinical characteristics between nine patients with 7p alterations and 88 patients with no 7p alterations; however, there was a difference in the status of IGF2 (uniparental disomy, loss of imprinting, or retention of imprinting) between the two patient groups (P = 0.028). Losses of MEOX2 and SOSTDC1 may accelerate angiogenesis and augment signals in the Wnt pathway, respectively. Both genes may be prime candidates for 7p tumor suppressor genes, which may have a role in the progression of Wilms tumorigenesis. © 2009 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Analysis of a new homozygous deletion in

Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes

✍ Debora Angeloni; Arja ter Elst; Ming Hui Wei; Anneke Y. van der Veen; Eleonora A 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 835 KB

## Abstract Homozygous deletions or loss of heterozygosity (LOH) at human chromosome band 3p12 are consistent features of lung and other malignancies, suggesting the presence of a tumor suppressor gene(s) (TSG) at this location. Only one gene has been cloned thus far from the overlapping region del

Homozygous deletion at the 9q32–33 candi

Homozygous deletion at the 9q32–33 candidate tumor suppressor locus in primary human bladder cancer

✍ Hiroyuki Nishiyama; Takeshi Takahashi; Yoshiyuki Kakehi; Tomonori Habuchi; Marga 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

Loss of heterozygosity (LOH) on chromosome arm 9q is the most frequent genetic alteration found in superficial and invasive transitional cell carcinoma (TCC) in a previous microsatellite-based deletion mapping study of the bladder and upper urinary tract, indicating the presence of one or more impor

The microcell hybrid-based “elimination

The microcell hybrid-based “elimination test” identifies a 1-Mb putative tumor-suppressor region at 3p22.2–p22.1 centromeric to the homozygous deletion region detected in lung cancer

✍ Irina D. Kholodnyuk; Marija Kost-Alimova; Ying Yang; Hajnalka Kiss; Ludmila Fedo 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB

## Abstract We have previously shown that inoculation of human chromosome 3 (chr3)/A9 mouse fibrosarcoma microcell hybrids (MCHs) into severely combined immunodeficient (SCID) mice was followed by the regular elimination of certain 3p regions, whereas a 3q region was retained even after prolonged m

Identification of a candidate tumor supp

Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer

✍ Levent B. Beder; Mehmet Gunduz; Mamoru Ouchida; Esra Gunduz; Akiko Sakai; Kunihi 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 364 KB

Frequency of mutation and deletion of th

Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population

✍ K Biden; J Young; R Buttenshaw; J Searle; G Cooksley; D B Xu; B Leggett 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB

The tumor suppressor gene CDKN2A (MTS1/p16), located on chromosome 9p21, is inactivated in a variety of tumors including melanomas and tumors of the biliary tract, pancreas, and stomach. The aim of the present study was to determine whether this gene is inactivated in hepatocellular carcinoma (HCC).

Detailed deletion mapping of chromosome

Detailed deletion mapping of chromosome arm 3p in breast cancers: A 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors

✍ Satoshi Matsumoto; Fujio Kasumi; Goi Sakamoto; Masahiko Onda; Yusuke Nakamura; M 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

Loss of heterozygosity (LOH) on 3p is frequent in human renal cell carcinomas, lung cancers, and breast cancers. To define the region(s) on 3p that harbor presumptive tumor suppressor gene(s) for breast cancer, we examined 196 primary breast tumors for their patterns of LOH at 22 microsatellite mark